Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | INDIAN IMMUNOLOGICALS LIMITED | 1 | ₹94.8 Cr |
| 2 | Schedule 5 | BIOLOGICAL E. LIMITED | 1 | ₹13.9 Cr |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
18 Nov 2024, 4:00 pmClosed
Measles- Rubella (MR) Vaccine under Universal Immunization Programme of MoHFW (Q1)
IP Vaccine under Universal Immunization programme of MoHFW (Q1)
Rotavirus Vaccine under Universal Immunization Programme of MoHFW (Q1)
BOP Vaccine under Universal Immunization programme of MoHFW (Q1)
Tetanus Toxoid with Adult Diphtheria (Td) Vaccine under Universal Immunization Programme of MoHFW (Q1)
7033859
GEM/2024/B/5515077
Two Packet Bid
Measles- Rubella (MR) Vaccine under Universal Immunization Programme of MoHFW,IP Vaccine under Univ
GeM Contract
750000 days
Delhi; New Delhi
Item wise evaluation
PRODUCT
Awarded to INDIAN IMMUNOLOGICALS LIMITED
₹94.8 Cr
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| MEBELLA Measles- Rubella (MR) Vaccine under Universal Immunization Programme of MoHFW | MEBELLA / Measles- Rubella (MR) Vaccine Under Universal Immu | HSN not specified by seller | 15,437,500 dose(s) | 61.4 | 947,862,500 |
Awarded to BIOLOGICAL E. LIMITED
₹13.9 Cr
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| Unbranded--BIOLOGICAL E. LIMITED Tetanus Toxoid with Adult Diphtheria (Td) Vaccine under Universal Immunization Programme of MoHFW | Unbranded--BIOLOGICAL E. LIMITED / VACCINE | 30022022 | 13,000,000 dose(s) | 10.66 | 138,580,000 |
11 documents required · 11 mandatory
3 yrs
₹3
10%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Measles- Rubella (MR) Vaccine under Universal Immunization Programme of MoHFW (Q1) | - | - | - |
| IP Vaccine under Universal Immunization programme of MoHFW (Q1) | - | - | - |
| Rotavirus Vaccine under Universal Immunization Programme of MoHFW (Q1) | - | - | - |
| BOP Vaccine under Universal Immunization programme of MoHFW (Q1) | - | - | - |
| Tetanus Toxoid with Adult Diphtheria (Td) Vaccine under Universal Immunization Programme of MoHFW (Q1) | - | - | - |
Exempted
28 Mar 2025
17 Oct 2024
18 Nov 2024
contract_GEMC-511687728079215.pdf
GEM_CONTRACT • 0.06 MB
contract_GEMC-511687756340375.pdf
GEM_CONTRACT
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7033859.pdf
GEM_BID
measles-_rubella__mr__vaccine-1_2022-04-12-17-41-12_b3dc622f999ed436cd10f430ca8c2902.pdf
OTHER
techspecipv_2021-10-08-18-00-16_a7b4959a5a45c5185259191f3204e0c4.pdf
OTHER
rotavirus_vaccine-1_2022-04-12-17-48-33_b689c222314c0648208d28bcd13eba89.pdf
OTHER
techspecbopv_2021-10-13-10-57-55_8d36aa8e15ba7d72a05affb30139d3dd.pdf
OTHER
tetanus_toxoid_with_adult_diphtheria__td__vaccine-1_2022-04-12-17-55-05_c75edfa8b5e03ca79f6dcb192944a883.pdf
OTHER
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .